The RUDY Study

Did you know that RUDY Study data was included in the recent NICE evaluation in understanding XLH in children? We would like to highlight how important projects like RUDY is and the role it plays when researchers work with the data to better understand disease impact....

James Lind Alliance Rare Musculoskeletal Diseases PSP

Today we have launched the Rare Musculoskeletal Diseases in Adulthood Priority Setting Partnership (PSP). I’m very happy to share the outcomes from the James Lind Alliance Rare Musculoskeletal Diseases PSP. Many of you gave your time to submit questions and to...

ECTS 2018 report

XLH UK attended the European Calcified Tissue Society congress (ECTS) in Valencia, Spain. We were also fortunate to attend the first Rare Bone Group meeting alongside the congress to meet and work with other rare bone groups. Please do have a look at the report...

Genetic Disorders UK, Leadership Symposium

[vc_row full_width=”stretch_row” tablets_mt=”margin-sm-300t” mobile_mt=”margin-xs-25t” css=”.vc_custom_1579306546982{background-color: #ffffff !important;}”][vc_column][cs_headings style=”simple”...

Survey for adults to help with future treatments

Aged between 13-17, 18-25, 26+? Do you live in Finland, Ireland, France or the UK? And fall into these age categories 13-17, 18-25, 26+? Then, please read on because your input will influence the care for adults across Europe. This is the now the time to focus on...